Abstract:Abstract:The aim of this study is to evaluate whether patients who have no residual tumor at the time of a re-excision lumpectomy benefit from the addition of a radiation boost dose. The records of 535 patients treated with breastconserving therapy (BCT) for Stage I-II breast cancer were reviewed. The actuarial risk of local recurrence (LR) was determined for the 262 patients in this cohort who underwent re-excision lumpectomy. There was no significant difference in the 10-year freedom from local recurrence (F… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.